Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells.
about
Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsUsing gene-network landscape to dissect genotype effects of TCF7L2 genetic variant on diabetes and cardiovascular riskNovel common integration sites targeted by mouse mammary tumor virus insertion in mammary tumors have oncogenic activity.Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.TCF7L2 is a master regulator of insulin production and processing.Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation.Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ AgonistThe SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.TCF/LEFs and Wnt signaling in the nucleus.Exploration of liver cancer genomes.Expression and Splice Variant Analysis of Human TCF4 Transcription Factor in Esophageal Cancer.Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway.Alternative splicing within the Wnt signaling pathway: role in cancer development.UEG Week 2015 Poster PresentationsAberrant expression of alternative isoforms of transcription factors in hepatocellular carcinomaSPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation
P2860
Q27022532-9B9B2E28-CE98-417D-AA86-5250CA87A38CQ28272656-1A47BC49-A168-4720-AD51-83A2EAB64B56Q34075681-6E26C25E-74FC-4304-B953-728D01231A41Q34328494-CDD5F3C2-E322-49F6-9EAA-37681A5B515AQ34555421-F31F6ED4-2A52-47E2-A880-52E056EDEB90Q35128041-FE96CDC4-8CC8-4291-A8FD-CF40C44746C6Q35674852-BEFB4222-4009-46D1-AEE9-81DFC87D2ED5Q36980028-F66A951D-A241-479E-8D67-ADD18A7F25D3Q36997259-CE27B463-EF52-46D6-9205-5BBE7A84BCC9Q37179096-A3518C22-DAD0-4F89-B8EB-36B09AE81727Q38048246-C8400D4F-7D13-440A-85F3-73B5F8114AABQ38182833-486D7A60-74D2-4184-AB15-781406679BA6Q38900424-CC1F8215-CE34-439A-A9CE-B7E50D8165D7Q39464436-3BB10319-D9BA-4A05-9964-1764859F59ECQ53211105-605305B0-4C23-4DE3-8ADA-29943E6A2F0FQ56934656-9B78233A-04C6-4254-9BC1-03474367D4D7Q58603892-CFD942A0-7A22-4C93-8AEE-D0A764F8A414Q58723980-483584A3-47C6-4D76-BF95-8D18DAFC667D
P2860
Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of T-cell facto ...... epatocellular carcinoma cells.
@ast
Identification of T-cell facto ...... epatocellular carcinoma cells.
@en
Identification of T-cell facto ...... epatocellular carcinoma cells.
@nl
type
label
Identification of T-cell facto ...... epatocellular carcinoma cells.
@ast
Identification of T-cell facto ...... epatocellular carcinoma cells.
@en
Identification of T-cell facto ...... epatocellular carcinoma cells.
@nl
prefLabel
Identification of T-cell facto ...... epatocellular carcinoma cells.
@ast
Identification of T-cell facto ...... epatocellular carcinoma cells.
@en
Identification of T-cell facto ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P1476
Identification of T-cell facto ...... epatocellular carcinoma cells.
@en
P2093
Hironori Koga
Jack R Wands
John J Carroll
Orkhontuya Tsedensodnom
Sarah B Nambotin
Stephen A Rosenberg
P2860
P304
P356
10.1016/J.YEXCR.2011.01.015
P407
P577
2011-01-20T00:00:00Z